Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,990.00
Bid: 1,990.00
Ask: 1,992.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.101%)
Open: 1,951.00
High: 1,990.00
Low: 1,951.00
Prev. Close: 1,977.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up

Tue, 06th Nov 2012 09:03

AB Foods: Jefferies keeps hold rating and 1,365p target; Panmure Gordon ups target from 1,300p to 1,450p, hold rating kept; Investec keeps hold rating and 1,300p target.Aviva: Panmure Gordon maintains buy rating and 425p target.Babcock: Jefferies keeps buy rating and 970p target; Seymour Pierce keeps buy rating and 1,000p target; Panmure Gordon keeps hold rating and 940p target; Investec downgrades from buy to hold, 1,000p target kept.BT Group: Jefferies keeps buy rating and 260p target.Capital Shopping Centres: Seymour Pierce keeps reduce rating and 327p target; Jefferies keeps hold rating and 347p target.DS Smith: Investec downgrades from buy to hold, 225p target kept.Endace: Panmure Gordon raises target from 552p to 558p, buy rating kept.EnQuest: Jefferies keeps buy rating and 155p target.Faroe Petroleum: Seymour Pierce cuts target from 286p to 285p, buy rating kept; Panmure Gordon keeps buy rating and 205p target.G4S: Seymour Pierce keeps hold rating and 255p target; Panmure Gordon keeps hold rating and 262p target.Hikma: Jefferies keeps buy rating and 890p target; Panmure Gordon upgrades from hold to buy, target lifted from 720p to 825p.Hilton Food: Panmure Gordon keeps buy rating and 315p target.IAG: Investec keeps buy rating and 190p target.IG Group: Investec cuts target from 625p to 600p, buy rating kept.Imagination Technologies: Jefferies keeps buy rating and 724p target.IMI: Panmure Gordon downgrades from buy to hold, target cut from 1,140p to 1,040p.InterContinental Hotels: Panmure Gordon keeps hold rating and 1,670p target; Investec keeps buy rating and 1,950p target.ITV: Westhouse Securities upgrades to buy.Kofax: Panmure Gordon ups target from 301p to 306p, buy rating kept.London & Stamford: Seymour Pierce upgrades from hold to buy, target under review; Jefferies keeps hold rating and 109p target.Marks & Spencer: Seymour Pierce raises target from 325p to 265p, hold rating kept; Panmure Gordon keeps hold rating and 389p target; Investec keeps sell rating and 275p target.Meggitt: Investec keeps buy rating and 435p target.Morgan Sindall: Jefferies keeps buy rating and 840p target.Ryanair: Panmure Gordon raises target from €5.00 to €5.50, buy rating kept.Senior: Investec keeps buy rating and 215p target.SQS Software Quality: Panmure Gordon keeps hold rating and 234p target.TalkTalk: Goldman Sachs upgrades to buy, target lifted from 250p to 290p.Talvivaara: Seymour Pierce keeps hold rating.Telecity: Jefferies keeps hold rating and 790p target; UBS cuts target from 975p to 945p, buy rating kept.Weir: Investec ups target from 1,850p to 2,020p, buy rating kept.BC
More News
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.